Research exploring hop-derived bioactive compounds (α-acids, β-acids, and xanthohumol) as natural antimicrobial preservatives for all-purpose cleaning formulations.
This research investigates the potential of hop extracts as natural preservatives in all-purpose cleaners (APCs). Hops have a well-established history in the brewing industry, where they were first introduced to extend product shelf-life before their bittering properties became widely recognized. Recent scientific findings suggest that hop-derived compounds may offer significant antimicrobial benefits beyond brewing applications.
The project focuses on three key bioactive ingredients found in hops: α-acids, β-acids, and xanthohumol. These compounds have demonstrated strong inhibitory effects against a range of pathogens, including gram-positive bacteria and mycobacterium bovis. The research aims to translate these antimicrobial properties into practical preservation solutions for cleaning products, potentially replacing synthetic preservatives with natural alternatives.
Active ingredients under investigation:
Research methodology:
The research builds on existing evidence that hop extracts, particularly when used as mixtures, show strong inhibitory effects against E. coli and other gram-negative bacterial strains.
This research is at an early-to-mid stage of development. The hypothesis is supported by numerous existing studies and a growing body of literature on the antimicrobial properties of hop extracts. Future validation work will systematically explore the inhibitory effects of the three hop active ingredients against target pathogens, determine optimal concentrations, and assess how formulation parameters affect antibacterial performance. The collaborative research environment at the University of Leeds supports both antimicrobial and physicochemical investigations needed to advance this technology toward commercial application.
The University of Leeds is a comprehensive, research‑intensive public university serving a large student body and global partner network. Industry partners engage through an on‑campus innovation hub offering flexible workspace, shared labs and prototyping, and options to co‑locate with academic experts. The university’s integration with major NHS teaching hospitals in the city enables clinical research, validation, and translation. Research is backed by competitive funding from UK Research and Innovation (UKRI) councils and the National Institute for Health and Care Research, with additional European and industry support. A dedicated technology transfer office manages IP, licensing, and spinouts, with partnership models and professional education tailored for corporate R&D.